Key result
TEVAR triggers a thrombo-inflammatory response that drives false-lumen thrombosis and aortic remodeling in TBAD.
Why the study?
The biological consequences of thoracic endovascular aortic repair in type B aortic dissection remain substantially less understood than its mechanical effects. This review examines the immune, thrombotic, cellular, and extracellular matrix responses associated with stent-graft implantation and their relationship to false-lumen healing and aortic remodeling.
Answers are grounded in this paper and cite their sources.
This review highlights that post-TEVAR inflammation in type B aortic dissection is a complex composite biological response that plays a dual role in false-lumen healing and adverse aortic remodeling, calling for integrated longitudinal immune phenotyping and imaging.
Thoracic endovascular aortic repair (TEVAR) has transformed the management of type B aortic dissection (TBAD), yet its biological consequences remain substantially less understood than its mechanical effects. Stent-graft implantation occurs within an already injured and immunologically active aorta, creating a new interface between circulating blood, biomaterial, thrombus, endothelium, and the dissected aortic wall. This review examines the immune, thrombotic, cellular, and extracellular matrix responses associated with TEVAR and proposes a framework linking these processes to false-lumen healing and aortic remodeling. Evidence from clinical, translational, biomaterial, imaging, and experimental studies was critically integrated to examine pre-existing inflammatory activity in TBAD; blood–stent-graft interactions; complement, platelet, neutrophil, and monocyte/macrophage responses; post-implantation syndrome; false-lumen thrombosis and organization; endothelial and extracellular-matrix remodeling; and emerging approaches to longitudinal immune phenotyping. Available evidence supports a model in which post-TEVAR inflammation represents a composite response arising from pre-existing dissection biology, procedural injury, biomaterial exposure, altered mechanobiology, and therapeutically induced thrombosis rather than an isolated device reaction. Early immunothrombotic activation may contribute to false-lumen thrombosis and subsequent organization, whereas persistent immune activation, proteolysis, residual perfusion, and failure of inflammatory resolution may accompany adverse remodeling. Conventional markers such as fever, leukocytosis, C-reactive protein, and post-implantation syndrome provide limited mechanistic resolution. Integration of serial cellular and molecular phenotyping with quantitative imaging may better distinguish adaptive healing from persistent thrombo-inflammatory activity. TEVAR should be understood as both a mechanical intervention and a biological perturbation. The clinically relevant objective is not simply to quantify postoperative inflammation, but to define its origin, cellular composition, temporal evolution, and relationship to false-lumen organization and structural remodeling. Prospective longitudinal studies integrating immune phenotyping, device characteristics, quantitative imaging, and selected proteomic, single-cell, and spatial approaches are needed before immune signatures can guide prognosis or therapeutic intervention.
No takes yet. Share an insight, caveat, or question.
Krasiński et al. (2026) conducted a review in Type B aortic dissection (TBAD). Thoracic endovascular aortic repair (TEVAR) stent-graft implantation was evaluated. Thoracic endovascular aortic repair (TEVAR) induces a composite thrombo-inflammatory response that shapes false-lumen thrombosis, organization, and structural aortic remodeling in TBAD.
Synapse has enriched 10 related papers. Consider them for comparative context: